Watchlist Price Alert

Antares Pharma Inc. (ATRS)

NASDAQ: ATRS · Real-Time Price · USD

5.59

0.01 (0.18%)

At close: Apr 24, 2025, 3:47 PM

Antares Pharma Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	183.46M	183.98M	179.38M	171.2M	158.6M	149.6M	143.31M	137.61M	133.66M	123.86M	104.85M	88.41M	74.14M	63.55M	58.77M	55.96M	55.21M	54.52M	54.67M	53.1M	51.91M	52.22M	49.83M	47.44M	49.63M
Cost of Revenue	70.6M	68.28M	68.37M	68.46M	64.5M	63.1M	58.07M	54.61M	54.58M	50.48M	46.08M	40.31M	34.83M	31.07M	28.54M	29.78M	28.43M	27.47M	27.05M	26.56M	28.26M	28.82M	28.1M	25.17M	22.56M
Gross Profit	112.85M	115.7M	111.01M	102.74M	94.11M	86.5M	85.24M	83M	79.08M	73.39M	58.77M	48.1M	39.31M	32.49M	30.23M	26.18M	26.78M	27.05M	27.62M	26.54M	23.65M	23.41M	21.73M	22.27M	27.07M
Operating Income	56.89M	65.25M	26.24M	24.13M	20.38M	13.62M	13.09M	9.23M	4.6M	992K	2.21M	-1.14M	-3.46M	-4.1M	-14.91M	-18.5M	-17.3M	-16.45M	-16.65M	-17.84M	-21.17M	-24.12M	-26.39M	-26.02M	-21.43M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	54.75M	62.27M	22.27M	20.05M	16.66M	9.92M	9.51M	5.56M	1.16M	-2.03M	-588K	-3.57M	-5.86M	-6.51M	-16.36M	-19.88M	-18.2M	-16.74M	-17.43M	-18.1M	-21.32M	-24.24M	-26.29M	-25.91M	-21.35M
Net Income	42.46M	48.58M	67.28M	66.88M	62.35M	56.2M	9.51M	5.56M	1.16M	-2.03M	-588K	-3.57M	-5.86M	-6.51M	-16.36M	-19.88M	-18.2M	-16.74M	-17.53M	-18.2M	-21.42M	-24.34M	-26.47M	-26.08M	-21.53M
Selling & General & Admin	76.85M	73.86M	71.84M	67.2M	63.94M	62.76M	61.47M	62.62M	63.26M	61.77M	59.56M	51.51M	43.88M	36.76M	30.95M	30.8M	30.7M	30.35M	29.17M	26.6M	26.26M	26.39M	26.92M	27.91M	27.5M
Research & Development	16.87M	14.5M	12.93M	11.41M	9.78M	10.12M	10.68M	11.14M	11.22M	10.62M	9.49M	10.24M	11.39M	12.33M	14.19M	13.87M	13.38M	13.15M	15.11M	17.78M	18.57M	21.13M	21.2M	20.38M	21M
Other Expenses	18.97M	18.97M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	112.69M	107.33M	84.77M	78.61M	73.72M	72.88M	72.15M	73.76M	74.48M	72.4M	69.05M	61.74M	55.28M	49.09M	45.14M	44.68M	44.08M	43.5M	44.27M	44.38M	44.82M	47.52M	48.12M	48.29M	48.5M
Interest Expense	2.06M	2.85M	3.82M	3.86M	3.69M	3.79M	3.89M	4.2M	3.95M	3.55M	3.19M	2.76M	2.71M	2.67M	2.59M	2.54M	1.89M	1.25M	625.94K	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	183.29M	175.61M	153.14M	147.07M	138.22M	135.98M	130.22M	128.37M	129.05M	122.87M	115.13M	102.05M	90.1M	80.16M	73.68M	74.45M	72.51M	70.97M	71.32M	70.94M	73.08M	76.34M	76.22M	73.46M	71.06M
Income Tax Expense	12.29M	13.7M	-45.01M	-46.91M	-45.66M	-46.18M	311K	527K	502K	530K	385K	338K	308K	261K	1.13M	1.16M	989.88K	962.81K	128.81K	25.05K	136.17K	158.31K	233.31K	247.38K	211.41K
Shares Outstanding (Basic)	170.1M	170.05M	169.95M	169.04M	167.82M	166.74M	166.38M	165.7M	165.43M	156.5M	163.12M	162.73M	160.45M	153.35M	157.47M	157.02M	156.72M	156.66M	156.4M	155.93M	155.22M	155.11M	155.06M	154.94M	154.86M
Shares Outstanding (Diluted)	170.1M	174.11M	175.13M	174.81M	174.91M	171.41M	169.66M	169.23M	165.43M	156.5M	168.5M	162.73M	160.45M	153.35M	157.47M	157.02M	156.72M	156.66M	156.4M	155.93M	155.22M	155.11M	155.06M	154.94M	154.86M
EPS (Basic)	0.25	0.28	0.40	0.40	0.38	0.34	0.06	0.04	0.01	-0.01	-0.00	-0.02	-0.04	-0.04	-0.1	-0.13	-0.12	-0.11	-0.11	-0.12	-0.14	-0.16	-0.17	-0.17	-0.14
EPS (Diluted)	0.25	0.28	0.39	0.39	0.36	0.33	0.06	0.03	0.01	-0.01	-0.00	-0.02	-0.04	-0.04	-0.1	-0.13	-0.12	-0.11	-0.11	-0.12	-0.14	-0.16	-0.17	-0.17	-0.14
EBITDA	60.75M	69.02M	29.75M	27.21M	23.3M	16.34M	15.77M	12.11M	7.55M	4.08M	5.43M	2.05M	-358K	-1.12M	-11.38M	-15M	-14.1M	-13.38M	-14.79M	-16.16M	-19.38M	-22.38M	-24.52M	-24.21M	-19.75M
EBIT	14.67M	20.01M	26.1M	23.9M	20.35M	13.71M	13.4M	9.76M	5.11M	1.52M	2.6M	-804K	-3.16M	-3.84M	-13.78M	-17.34M	-13.47M	-7.91M	-4.83M	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	3.94M	3.9M	3.66M	3.31M	2.95M	2.63M	2.37M	2.35M	2.45M	2.56M	2.83M	2.85M	2.8M	2.72M	2.39M	2.34M	2.21M	2.1M	2.01M	1.94M	1.94M	1.86M	1.77M	1.69M	1.6M